Here O
we O
describe O
the O
cloning O
, O
tissue O
- O
specific O
expression O
pattern O
, O
and O
functional O
characterization O
of O
two O
novel O
TEF B
- I
1 I
isoforms I
, O
TEF B
- I
1beta I
and O
TEF B
- I
1gamma I
. O

Phosphatidylinositol B
3 I
- I
kinase I
requirement O
in O
activation O
of O
the O
ras B
/ O
C B
- I
raf I
- I
1 I
/ O
MEK B
/ O
ERK B
and O
p70 B
( O
s6k B
) O
signaling O
cascade O
by O
the O
insulinomimetic O
agent O
vanadyl O
sulfate O
. O

Sequence O
analysis O
of O
the O
promoter O
region O
showed O
no O
TATA O
box O
but O
identified O
consensus O
binding O
motifs O
for O
Sp1 B
, O
CREB B
, O
and O
half O
sites O
of O
the O
estrogen B
receptor I
binding I
site I
. O

While O
all O
deletions O
within O
the O
sequence O
coding O
for O
the O
mature O
tRNA O
led O
to O
inactivity O
of O
the O
mutated O
genes O
, O
substitution O
of O
the O
central O
portion O
by O
concatenated B
Hind I
III I
linkers I
produced O
gene O
units O
active O
in O
transcription O
. O

CONCLUSION O
: O
Treatment O
of O
sepsis O
with O
the O
platelet B
- I
activating I
factor I
antagonist O
BB O
- O
882 O
offers O
no O
advantage O
over O
placebo O
on O
survival O
, O
hemodynamic O
status O
, O
respiratory O
function O
, O
or O
organ O
failure O
scores O
. O

An O
aromatic O
stacking O
interaction O
between O
subunits O
helps O
mediate O
DNA O
sequence O
specificity O
: O
operator O
site O
discrimination O
by O
phage B
lambda I
cI I
repressor I
. O

We O
have O
previously O
shown O
that O
the O
adenoviral B
12S I
E1A I
protein I
modulates O
the O
phosphorylation O
status O
of O
p130 B
and O
p107 B
without O
apparent O
changes O
in O
the O
cell O
cycle O
dependent O
phosphorylation O
of O
the O
retinoblastoma B
protein I
. O

The O
5 O
' O
flanking O
region O
contains O
potential O
binding O
sites O
for O
TATA B
- I
binding I
protein I
, O
Sp1 B
, O
nuclear B
factor I
1 I
( O
NF1 B
) O
, O
CAAT B
- I
box I
binding I
protein I
( O
C B
/ I
EBP I
) O
, O
hepatocyte B
nuclear I
factors I
1 I
and I
5 I
( O
HNF1 B
, O
HNF5 B
) O
and O
activator B
proteins I
1 I
and I
2 I
( O
AP1 B
, O
AP2 B
) O
. O

In O
contrast O
, O
transiently O
transfected O
cells O
expressing O
EBNA B
- I
3 I
revealed O
a O
sixfold O
increase O
in O
EBNA B
- I
3 I
protein I
expression O
from O
the O
genomic O
EBNA B
- I
3 I
gene I
compared O
to O
EBNA B
- I
3 I
cDNA I
. O

In O
contrast O
, O
transiently O
transfected O
cells O
expressing O
EBNA B
- I
3 I
revealed O
a O
sixfold O
increase O
in O
EBNA B
- I
3 I
protein I
expression O
from O
the O
genomic O
EBNA B
- I
3 I
gene I
compared O
to O
EBNA B
- I
3 I
cDNA I
. O

In O
contrast O
, O
transiently O
transfected O
cells O
expressing O
EBNA B
- I
3 I
revealed O
a O
sixfold O
increase O
in O
EBNA B
- I
3 I
protein I
expression O
from O
the O
genomic O
EBNA B
- I
3 I
gene I
compared O
to O
EBNA B
- I
3 I
cDNA I
. O

In O
addition O
, O
the O
calbindin B
- I
D28K I
promoter I
is O
composed O
of O
a O
variety O
of O
simple O
repeated O
sequences O
, O
some O
of O
which O
are O
components O
of O
putative O
regulatory O
signals O
. O

The O
gene O
encoding O
TRP B
- I
2 I
maps O
to O
mouse O
chromosome O
14 O
, O
in O
the O
region O
of O
the O
coat B
colour I
mutation I
slaty I
. O

Here O
we O
have O
examined O
the O
ability O
of O
the O
cellular O
protein O
YB B
- I
1 I
to O
modulate O
transcription O
of O
the O
HIV B
- I
1 I
promoter I
in O
a O
human O
astrocytic O
cell O
line O
( O
U O
- O
87MG O
) O
, O
a O
neuronal O
cell O
line O
( O
SK O
- O
N O
- O
MC O
) O
and O
lymphoid O
cells O
( O
Jurkat O
) O
by O
transfection O
assay O
. O

Potentiation O
of O
the O
thrombolytic O
efficacy O
of O
single B
- I
chain I
urokinase I
( O
Pro B
- I
urokinase I
) O
by O
heparin O
. O

Using O
mouse O
- O
human O
somatic O
hybrids O
and O
FISH O
analysis O
, O
the O
PE B
- I
2 I
gene I
is O
localized O
to O
human O
chromosome O
19q13 O
. O
2 O
, O
a O
region O
involved O
in O
translocations O
and O
deletions O
in O
leukemias O
and O
several O
solid O
tumors O
, O
suggesting O
that O
this O
novel O
ETS B
factor I
may O
play O
a O
role O
in O
carcinogenesis O
. O

In O
order O
to O
examine O
the O
potential O
role O
of O
transcriptional O
silencing O
during O
productive O
HSV O
- O
1 O
infection O
, O
recombinant O
viruses O
were O
generated O
in O
which O
wild B
- I
type I
or I
mutant I
ICP34 I
. I
5 I
promoters I
controlling O
the O
expression O
of O
a O
chloramphenicol B
acetyltransferase I
reporter I
gene I
were O
inserted O
into O
the O
thymidine B
kinase I
gene I
of O
the O
viral O
genome O
. O

Dilutions O
of O
H B
- I
2b I
or I
H I
- I
2d I
NP I
peptides I
indicated O
that O
3 O
- O
4 O
logs O
less O
H B
- I
2b I
NP I
peptide I
was O
required O
to O
sensitize O
syngeneic O
target O
cells O
for O
CTL O
- O
specific O
lysis O
, O
suggesting O
that O
the O
differing O
affinities O
of O
H O
- O
2b O
and O
H O
- O
2d O
major B
histocompatibility I
complex I
molecules I
for O
their O
peptides O
likely O
account O
for O
the O
total O
removal O
of O
NP O
CTL O
in O
the O
H O
- O
2b O
mice O
but O
only O
partial O
removal O
in O
H O
- O
2d O
mice O
made O
to O
express O
thymic O
NP O
. O

We O
have O
isolated O
a O
Drosophila O
melanogaster O
( O
Dm O
) O
cDNA O
encoding O
a O
polypeptide O
that O
has O
extensive O
sequence O
similarity O
to O
the O
mammalian B
MAPKAPK I
- I
2 I
. O

It O
bound O
to O
vitamin B
D I
receptor I
( O
VDR B
) O
but O
not O
retinoic B
acid I
Xalpha I
receptor I
( O
RXRalpha B
) O
in O
the O
human O
T O
cell O
line O
MT2 O
cells O
. O

EMSA O
with O
crude O
nuclear O
extracts O
demonstrated O
that O
stimulation O
with O
CD40L B
results O
in O
the O
induction O
of O
NF B
- I
kappaB I
complexes I
that O
bind O
to O
each O
of O
the O
three O
NF B
- I
kappaB I
sites I
and O
are O
composed O
mainly O
of O
p50 B
and O
RelB B
, O
but O
also O
include O
c B
- I
Rel I
and O
p65 B
. O

EMSA O
with O
crude O
nuclear O
extracts O
demonstrated O
that O
stimulation O
with O
CD40L B
results O
in O
the O
induction O
of O
NF B
- I
kappaB I
complexes I
that O
bind O
to O
each O
of O
the O
three O
NF B
- I
kappaB I
sites I
and O
are O
composed O
mainly O
of O
p50 B
and O
RelB B
, O
but O
also O
include O
c B
- I
Rel I
and O
p65 B
. O

Although O
metabolized O
by O
the O
cytochrome B
P I
- I
450 I
( O
CYP B
) O
system O
, O
venlafaxine O
inhibits O
CYP B
2D6 I
and I
3A4 I
to O
a O
far O
lesser O
extent O
than O
do O
the O
SSRIs O
. O

Although O
metabolized O
by O
the O
cytochrome B
P I
- I
450 I
( O
CYP B
) O
system O
, O
venlafaxine O
inhibits O
CYP B
2D6 I
and I
3A4 I
to O
a O
far O
lesser O
extent O
than O
do O
the O
SSRIs O
. O

It O
is O
now O
well O
accepted O
that O
the O
p53 B
C I
- I
terminus I
plays O
a O
central O
role O
in O
controlling O
the O
activity O
of O
the O
wild O
- O
type O
molecule O
. O

Comparison O
with O
the O
sequence O
databanks O
show O
that O
Tactile B
is O
a O
member O
of O
the O
immunoglobulin B
gene I
superfamily I
, O
with O
similarity O
to O
Drosophila B
amalgam I
, O
the O
melanoma B
Ag I
MUC I
- I
18 I
, O
members O
of O
the O
carcinoembryonic B
Ag I
family I
, O
the O
poliovirus B
receptor I
, O
and O
the O
neural B
cell I
adhesion I
molecule I
. O

Experimental O
adhesion O
prophylaxis O
with O
recombinant B
tissue I
plasminogen I
activator I
. O

The O
primary O
structure O
and O
cotranscription O
of O
the O
petCA B
genes I
encoding O
the O
Rieske B
- I
FeS I
( O
nuclear B
encoded I
in I
plants I
) O
and O
apocytochrome B
f I
proteins I
has O
been O
described O
previously O
( O
Kallas O
, O
T O
. O
, O
Spiller O
, O
S O
. O
, O
and O
Malkin O
, O
R O
. O

HeLa O
and O
Jurkat O
cell O
lines O
carrying O
the O
nef B
gene I
linked O
to O
the O
CMV O
promoter O
or O
the O
HIV B
- I
1 I
LTR I
were O
isolated O
by O
coselection O
for O
neomycin O
resistance O
. O

Two O
separate O
NF1 B
- I
binding I
loci I
were O
also O
found O
in O
the O
equivalent O
IE68 B
gene I
of O
HCMV O
( O
Towne O
) O
DNA O
, O
but O
in O
this O
case O
the O
DNA O
sequence O
and O
competition O
filter O
binding O
experiments O
indicated O
a O
maximum O
of O
only O
four O
to O
five O
consensus O
binding O
sites O
encompassing O
the O
promoter O
- O
enhancer O
region O
. O

The O
absolute O
concentrations O
of O
alpha B
2 I
- I
plasmin I
inhibitor O
, O
alpha B
2 I
- I
macroglobulin I
, O
and O
antithrombin B
III I
increased O
with O
exercise O
( O
all O
P O
less O
than O
0 O
. O
005 O
) O
, O
but O
when O
concentrations O
were O
corrected O
for O
acute O
shifts O
of O
plasma O
water O
during O
exercise O
, O
the O
quantity O
of O
these O
inhibitors O
actually O
decreased O
( O
all O
P O
less O
than O
0 O
. O
005 O
) O
. O

The O
absolute O
concentrations O
of O
alpha B
2 I
- I
plasmin I
inhibitor O
, O
alpha B
2 I
- I
macroglobulin I
, O
and O
antithrombin B
III I
increased O
with O
exercise O
( O
all O
P O
less O
than O
0 O
. O
005 O
) O
, O
but O
when O
concentrations O
were O
corrected O
for O
acute O
shifts O
of O
plasma O
water O
during O
exercise O
, O
the O
quantity O
of O
these O
inhibitors O
actually O
decreased O
( O
all O
P O
less O
than O
0 O
. O
005 O
) O
. O

Basal O
components O
of O
the O
transcription O
apparatus O
( O
RNA B
polymerase I
II I
, O
TATA B
- I
binding I
protein I
) O
contain O
activation O
domains O
: O
is O
the O
repetitive O
C O
- O
terminal O
domain O
( O
CTD O
) O
of O
RNA B
polymerase I
II I
a O
" O
portable O
enhancer O
domain O
" O
? O

A O
comparison O
of O
the O
promoters O
for O
muMIP B
- I
1 I
beta I
and O
muMIP B
- I
1 I
alpha I
reveals O
a O
conserved O
CK O
- O
1 O
element O
, O
but O
transient O
expression O
studies O
in O
RAW O
264 O
. O
7 O
macrophages O
with O
proximal O
fragments O
of O
either O
the O
muMIP B
- I
1 I
beta I
or O
the O
muMIP B
- I
1 I
alpha I
5 I
' I
promoter I
fused O
to O
a O
human B
growth I
hormone I
reporter I
gene I
link O
LPS O
- O
inducibility O
in O
both O
to O
promoter O
segments O
near O
to O
, O
but O
not O
identical O
with O
, O
the O
consensus O
CK O
- O
1 O
sequence O
. O

A O
comparison O
of O
the O
promoters O
for O
muMIP B
- I
1 I
beta I
and O
muMIP B
- I
1 I
alpha I
reveals O
a O
conserved O
CK O
- O
1 O
element O
, O
but O
transient O
expression O
studies O
in O
RAW O
264 O
. O
7 O
macrophages O
with O
proximal O
fragments O
of O
either O
the O
muMIP B
- I
1 I
beta I
or O
the O
muMIP B
- I
1 I
alpha I
5 I
' I
promoter I
fused O
to O
a O
human B
growth I
hormone I
reporter I
gene I
link O
LPS O
- O
inducibility O
in O
both O
to O
promoter O
segments O
near O
to O
, O
but O
not O
identical O
with O
, O
the O
consensus O
CK O
- O
1 O
sequence O
. O

A O
comparison O
of O
the O
promoters O
for O
muMIP B
- I
1 I
beta I
and O
muMIP B
- I
1 I
alpha I
reveals O
a O
conserved O
CK O
- O
1 O
element O
, O
but O
transient O
expression O
studies O
in O
RAW O
264 O
. O
7 O
macrophages O
with O
proximal O
fragments O
of O
either O
the O
muMIP B
- I
1 I
beta I
or O
the O
muMIP B
- I
1 I
alpha I
5 I
' I
promoter I
fused O
to O
a O
human B
growth I
hormone I
reporter I
gene I
link O
LPS O
- O
inducibility O
in O
both O
to O
promoter O
segments O
near O
to O
, O
but O
not O
identical O
with O
, O
the O
consensus O
CK O
- O
1 O
sequence O
. O

Moreover O
, O
the O
ability O
to O
selectivity O
arrest O
elongation O
by O
polIII B
at O
defined O
positions O
within O
the O
tRNA O
gene O
transcription O
unit O
has O
permitted O
the O
identification O
of O
discrete O
functional O
properties O
of O
paused O
mammalian B
polIII I
ternary I
complexes I
. O

The O
differential O
investigation O
of O
lipoproteins O
, O
however O
, O
showed O
that O
the O
high B
- I
density I
lipoprotein I
( O
HDL B
) O
fractions O
are O
absolutely O
or O
relatively O
decreased O
with O
respect O
to O
low B
- I
density I
lipoproteins I
( O
LDL B
) O
in O
cerebral O
infarcts O
and O
in O
transient O
ischaemic O
attacks O
. O

The O
differential O
investigation O
of O
lipoproteins O
, O
however O
, O
showed O
that O
the O
high B
- I
density I
lipoprotein I
( O
HDL B
) O
fractions O
are O
absolutely O
or O
relatively O
decreased O
with O
respect O
to O
low B
- I
density I
lipoproteins I
( O
LDL B
) O
in O
cerebral O
infarcts O
and O
in O
transient O
ischaemic O
attacks O
. O

The O
RNA O
- O
binding O
and O
RNA B
- I
DNA I
helicase I
activities O
of O
the O
Escherichia B
coli I
transcription I
termination I
factor I
rho I
have O
been O
investigated O
using O
natural O
RNA O
molecules O
that O
are O
255 O
and O
391 O
nucleotide O
residues O
in O
length O
and O
that O
contain O
the O
trp B
t I
' I
rho I
- I
dependent I
termination I
sequence I
of O
E O
. O
coli O
. O

Recruitment O
of O
an O
RNA B
polymerase I
II I
complex I
is O
mediated O
by O
the O
constitutive O
activation O
domain O
in O
CREB B
, O
independently O
of O
CREB B
phosphorylation O
. O

NF B
- I
kappaB I
, O
which O
is O
probably O
important O
for O
basal O
activity O
of O
the O
human B
NOS I
II I
promoter I
, O
is O
unlikely O
to O
function O
as O
a O
major O
effector O
of O
CM O
in O
DLD O
- O
1 O
cells O
. O

Because O
the O
Pit B
- I
1 I
sites I
in O
the O
hGH B
- I
N I
gene I
promoter I
are O
insufficient O
for O
such O
gene O
activation O
in O
vivo O
, O
these O
data O
suggested O
a O
unique O
chromatin O
- O
mediated O
developmental O
role O
for O
Pit B
- I
1 I
in O
the O
hGH B
LCR I
. O

A O
triple O
Ser O
- O
- O
> O
Ala O
mutant O
form O
of O
yeast O
eIF B
- I
2 I
alpha I
was O
found O
to O
be O
no O
longer O
phosphorylated O
by O
either O
of O
the O
yeast O
( O
or O
mammalian O
) O
casein B
kinase I
activities O
in O
vitro O
. O

In O
293 O
cells O
, O
expression O
of O
the O
NF B
- I
kappa I
B I
inhibitor O
, O
I B
kappa I
B I
- I
alpha I
, O
reduced O
the O
stimulatory O
activity O
of O
LMP B
. O

The O
E1 B
nuclear I
transport I
motif I
is O
highly O
conserved O
in O
the O
animal O
and O
human O
papillomaviruses O
and O
is O
encoded O
in O
a O
similar O
region O
in O
the O
related O
E1 B
genes I
. O

In O
11 O
patients O
with O
Horton O
' O
s O
headache O
morphological O
investigations O
( O
differential O
white O
blood O
cell O
count O
) O
, O
cytoenzymatic O
determinations O
( O
alkaline B
and I
acid I
phosphatase I
, O
non B
- I
specific I
esterase I
) O
and O
cytoimmunological O
tests O
( O
IgM B
and O
IgG B
binding O
) O
were O
carried O
out O
on O
capillary O
blood O
neutrophils O
obtained O
from O
the O
area O
of O
pain O
, O
non O
- O
painful O
area O
of O
the O
skin O
on O
the O
head O
on O
the O
contralateral O
side O
, O
and O
from O
the O
finger O
. O

In O
11 O
patients O
with O
Horton O
' O
s O
headache O
morphological O
investigations O
( O
differential O
white O
blood O
cell O
count O
) O
, O
cytoenzymatic O
determinations O
( O
alkaline B
and I
acid I
phosphatase I
, O
non B
- I
specific I
esterase I
) O
and O
cytoimmunological O
tests O
( O
IgM B
and O
IgG B
binding O
) O
were O
carried O
out O
on O
capillary O
blood O
neutrophils O
obtained O
from O
the O
area O
of O
pain O
, O
non O
- O
painful O
area O
of O
the O
skin O
on O
the O
head O
on O
the O
contralateral O
side O
, O
and O
from O
the O
finger O
. O

A O
vector O
containing O
a O
transcriptionally O
inactive O
neomycin B
phosphotransferase I
II I
gene I
was O
used O
to O
select O
promoter O
sequences O
from O
a O
pool O
of O
random O
genomic O
DNA O
fragments O
. O

In O
co O
- O
transfection O
studies O
, O
an O
AP B
- I
2 I
but O
not O
an O
Egr B
- I
1 I
expression O
vector O
activated O
VPF B
/ O
VEGF B
transcription O
, O
thus O
indicating O
that O
AP B
- I
2 I
protein I
is O
functionally O
important O
in O
TGF B
alpha I
- O
induced O
VPF B
/ O
VEGF B
gene O
expression O
. O

Hepatitis B
B I
surface I
antigen I
was O
detected O
in O
2 O
patients O
, O
with O
negative O
hepatitis B
C I
virus I
antibody I
. O

Hepatitis B
B I
surface I
antigen I
was O
detected O
in O
2 O
patients O
, O
with O
negative O
hepatitis B
C I
virus I
antibody I
. O

The O
results O
indicate O
that O
hrpRS B
and O
hrpL B
are O
part O
of O
a O
regulatory O
cascade O
in O
which O
HrpR B
and O
HrpS B
activate O
expression O
of O
hrpL B
and O
HrpL B
, O
a O
putative O
sigma B
factor I
, O
induces O
expression O
of O
HrpL B
- I
responsive I
genes I
. O

By O
in O
vitro O
immunoprecipitations O
and O
gel O
shift O
assays O
, O
we O
identified O
two O
classes O
of O
high O
affinity O
Engrailed B
- I
binding I
sites I
upstream O
of O
each O
of O
the O
two O
polyhomeotic O
transcription O
units O
. O

Surprisingly O
, O
there O
is O
no O
sequence O
homology O
between O
this O
region O
of O
Ly B
- I
6E I
and O
the O
established O
consensus O
for O
the O
interferon B
- I
stimulated I
response I
element I
, O
which O
has O
been O
shown O
functionally O
important O
to O
all O
previously O
characterized O
alpha B
/ I
beta I
interferon I
- O
inducible O
promoters O
. O

Analysis O
of O
lacZ B
transcriptional I
fusions I
shows O
that O
the O
KdgR B
- I
binding I
sites I
negatively O
affect O
the O
expression O
of O
rsmB B
. O

Expression O
of O
the O
human O
T B
cell I
receptor I
( I
TCR I
) I
alpha I
gene I
is O
regulated O
by O
a O
T O
cell O
- O
specific O
transcriptional O
enhancer O
that O
is O
located O
4 O
. O
5 O
kilobases O
( O
kb O
) O
3 O
' O
to O
the O
C B
alpha I
gene I
segment I
. O

This O
region O
also O
contains O
a O
gene O
specifying O
a O
Leu B
- I
tRNA I
precursor I
and O
a O
remnant O
of O
a O
tau O
element O
. O

Cytokine O
- O
induced O
NF B
- I
kappa I
B I
DNA O
binding O
activity O
, O
RelA B
nuclear O
translocation O
, O
I B
kappa I
B I
alpha I
degradation O
, O
I B
kappa I
B I
serine O
32 O
phosphorylation O
, O
and O
I B
kappa I
B I
kinase I
( O
IKK B
) O
activity O
were O
blocked O
by O
curcumin O
treatment O
. O

Cytokine O
- O
induced O
NF B
- I
kappa I
B I
DNA O
binding O
activity O
, O
RelA B
nuclear O
translocation O
, O
I B
kappa I
B I
alpha I
degradation O
, O
I B
kappa I
B I
serine O
32 O
phosphorylation O
, O
and O
I B
kappa I
B I
kinase I
( O
IKK B
) O
activity O
were O
blocked O
by O
curcumin O
treatment O
. O

Cytokine O
- O
induced O
NF B
- I
kappa I
B I
DNA O
binding O
activity O
, O
RelA B
nuclear O
translocation O
, O
I B
kappa I
B I
alpha I
degradation O
, O
I B
kappa I
B I
serine O
32 O
phosphorylation O
, O
and O
I B
kappa I
B I
kinase I
( O
IKK B
) O
activity O
were O
blocked O
by O
curcumin O
treatment O
. O

We O
found O
that O
T3 O
( O
10 O
( O
- O
8 O
) O
M O
) O
selectively O
stimulates O
transcription O
from O
rGH B
- O
TRE O
- O
and O
TREpal O
- O
, O
but O
not O
ME O
- O
TRE O
- O
and O
F2 O
- O
TRE O
- O
, O
containing O
templates O
in O
which O
these O
TREs O
are O
linked O
in O
front O
of O
the O
rGH B
minimal I
promoter I
containing O
only O
the O
TATA B
box I
binding I
protein I
, O
but O
not O
any O
other O
proximal O
binding O
protein O
, O
sequence O
. O

While O
determination O
of O
the O
protein O
content O
of O
the O
formulae O
gave O
no O
valid O
information O
, O
RAST O
/ O
EAST O
inhibition O
was O
highest O
for O
cow O
' O
s O
milk O
, O
followed O
by O
the O
partially O
hydrolysed O
whey O
formula O
, O
partially O
hydrolysed O
whey O
/ O
casein B
formula O
, O
soy B
/ I
pork I
collagen I
formula O
, O
and O
the O
amino O
acid O
formula O
. O

Members O
of O
the O
meis1 B
and O
pbx B
homeodomain I
protein I
families I
cooperatively O
bind O
a O
cAMP O
- O
responsive O
sequence O
( O
CRS1 O
) O
from O
bovine B
CYP17 I
. O

The O
role O
of O
HIV B
tat I
, O
which O
is O
the O
main O
enhancing O
factor O
for O
viral B
LTR I
, O
in O
the O
regulation O
of O
IL B
- I
2 I
gene I
transcription O
has O
been O
studied O
following O
transient O
expression O
of O
the O
tat B
gene I
in O
phorbol O
ester O
and O
calcium O
ionophore O
- O
activated O
Jurkat O
cells O
transfected O
with O
IL B
- I
2 I
promoter O
- O
chloramphenicol B
acetyltransferase I
reporter O
constructs O
. O

These O
data O
suggest O
that O
other O
Ras B
effectors I
can O
collaborate O
with O
PI B
3 I
- I
kinase I
and O
with O
each O
other O
to O
activate O
Pak B
. O

MSSPs B
are O
believed O
to O
regulate O
DNA O
replication O
, O
transcription O
, O
apopotosis O
and O
cell O
cycle O
progression O
by O
interacting O
with O
the O
C B
- I
MYC I
protein I
. O

Experimental O
data O
showed O
that O
these O
abnormal O
proteins O
are O
constitutively O
localized O
in O
the O
nucleus O
, O
have O
lost O
the O
transcriptional O
repressor O
functions O
typical O
of O
normal O
NF B
- I
kappa I
B2p52 I
and O
may O
be O
capable O
of O
transactivation O
activity O
. O

In O
addition O
, O
severe O
vision O
loss O
can O
be O
seen O
with O
interferon B
alfa I
- I
2b I
- O
associated O
retinopathy O
. O

Proteins O
known O
to O
bind O
the O
PEPCK B
CRE O
include O
the O
CRE B
- I
binding I
protein I
( O
CREB B
) O
and O
members O
of O
the O
CCAAT B
/ I
enhancer I
- I
binding I
protein I
( O
C B
/ I
EBP I
) O
family O
. O

Muscle B
GSH I
- I
Px I
activity O
after O
prolonged O
exercise O
, O
training O
, O
and O
selenium O
supplementation O
. O

Sp1 B
can O
activate O
transcription O
through O
immunoglobulin B
kappa I
- I
chain I
enhancer I
or O
P B
- I
selectin I
promoter I
NF B
- I
kappaB I
sites I
. O

Sp1 B
can O
activate O
transcription O
through O
immunoglobulin B
kappa I
- I
chain I
enhancer I
or O
P B
- I
selectin I
promoter I
NF B
- I
kappaB I
sites I
. O

p50 B
homodimers I
replace O
Sp1 B
from O
the O
P B
- I
selectin I
promoter I
by O
binding O
site O
competition O
and O
thereby O
either O
inhibit O
basal O
Sp1 B
- O
driven O
expression O
or O
, O
in O
concert O
with O
Bcl B
- I
3 I
, O
stimulate O
expression O
. O

A O
yeast O
DNA O
fragment O
carrying O
the O
gene B
CP I
A1 I
encoding O
the O
small O
subunit O
of O
the O
arginine O
pathway O
carbamoyl B
- I
phosphate I
synthetase I
has O
been O
sequenced O
. O

Interestingly O
, O
these O
response O
elements O
display O
dramatically O
reduced O
affinity O
for O
retinoic B
acid I
receptor I
- O
retinoid B
- I
X I
receptor I
heterodimers O
. O

She O
has O
since O
developed O
a O
positive O
anti B
- I
cardiolipin I
antibody I
but O
does O
not O
meet O
diagnostic O
criteria O
for O
systemic O
lupus O
erythematosis O
. O

The O
cwg2 B
- I
1 I
mutation I
was O
identified O
as O
a O
guanine O
to O
adenine O
substitution O
at O
nucleotide O
604 O
of O
the O
coding O
region O
, O
originating O
the O
change O
A202T O
in O
the O
cwg2p B
. O

Extracellular B
- I
regulated I
kinase I
( O
ERK B
) O
activation O
and O
molecular O
coupling O
of O
the O
adaptor O
proteins O
p130 B
Crk B
- I
associated I
substrate I
( O
CAS B
) O
and O
c B
- I
CrkII I
( O
Crk B
) O
represent O
two O
distinct O
pathways O
that O
induce O
cell O
invasion O
and O
protect O
cells O
from O
apoptosis O
in O
a O
three O
- O
dimensional O
collagen B
matrix O
. O

Extracellular B
- I
regulated I
kinase I
( O
ERK B
) O
activation O
and O
molecular O
coupling O
of O
the O
adaptor O
proteins O
p130 B
Crk B
- I
associated I
substrate I
( O
CAS B
) O
and O
c B
- I
CrkII I
( O
Crk B
) O
represent O
two O
distinct O
pathways O
that O
induce O
cell O
invasion O
and O
protect O
cells O
from O
apoptosis O
in O
a O
three O
- O
dimensional O
collagen B
matrix O
. O

DNA O
hybridization O
analysis O
revealed O
that O
both O
pigmented O
and O
nonpigmented O
cells O
of O
Y O
. O
pestis O
possess O
a O
DNA O
locus O
homologous O
to O
the O
Escherichia B
coli I
fur I
gene I
. O

NF B
- I
kappa I
B I
p65 B
, O
p50 B
, O
and O
Rel B
functionally O
synergize O
with O
C B
/ I
EBP I
alpha I
, O
C B
/ I
EBP I
beta I
, O
and O
C B
/ I
EBP I
delta I
. O

NF B
- I
kappa I
B I
p65 B
, O
p50 B
, O
and O
Rel B
functionally O
synergize O
with O
C B
/ I
EBP I
alpha I
, O
C B
/ I
EBP I
beta I
, O
and O
C B
/ I
EBP I
delta I
. O

NF B
- I
kappa I
B I
p65 B
, O
p50 B
, O
and O
Rel B
functionally O
synergize O
with O
C B
/ I
EBP I
alpha I
, O
C B
/ I
EBP I
beta I
, O
and O
C B
/ I
EBP I
delta I
. O

NF B
- I
kappa I
B I
p65 B
, O
p50 B
, O
and O
Rel B
functionally O
synergize O
with O
C B
/ I
EBP I
alpha I
, O
C B
/ I
EBP I
beta I
, O
and O
C B
/ I
EBP I
delta I
. O

Because O
L B
- I
plastin I
expression O
in O
tissue O
- O
specifically O
regulated O
in O
both O
humans O
and O
rodents O
, O
it O
is O
likely O
that O
similar O
mechanisms O
regulate O
L B
- I
plastin I
gene I
expression O
in O
human O
and O
rodent O
cells O
and O
that O
they O
could O
be O
identified O
by O
comparing O
the O
function O
and O
nucleotide O
sequences O
of O
the O
human O
and O
murine O
L B
- I
plastin I
gene O
promoters O
. O

Here O
we O
describe O
the O
identification O
and O
characterization O
of O
several O
Sp100 B
splice I
variant I
proteins I
and O
support O
their O
existence O
by O
elucidation O
of O
the O
3 O
' O
- O
end O
of O
the O
Sp100 B
gene I
. O

A O
motif O
( O
TGATGTCA O
) O
which O
matches O
a O
CREB B
site I
and O
is O
similar O
to O
an O
AP B
- I
1 I
site I
is O
embedded O
within O
ER2 B
. O

Localization O
of O
67 O
exons O
on O
a O
YAC O
contig O
spanning O
1 O
. O
5 O
Mb O
around O
the O
multidrug B
resistance I
gene I
region I
of O
human O
chromosome O
7q21 O
. O
1 O
. O

Southern O
blot O
analysis O
using O
probes O
from O
the O
3 O
' O
portions O
of O
the O
genomic O
and O
B B
. I
napus I
MA I
and O
MB B
cDNA I
clones O
showed O
that O
MA B
type I
myrosinases B
are O
encoded O
by O
approximately O
4 O
genes O
, O
while O
MB B
type I
myrosinases B
are O
encoded O
by O
more O
than O
10 O
genes O
in O
B O
. O
napus O
. O

A O
polypeptide O
encoded O
by O
the O
NTS O
16 O
open O
reading O
frame O
has O
sequence O
similarity O
to O
the O
catalytic O
domain O
of O
several O
receptor B
protein I
kinases I
from I
plants I
including O
the O
S B
- I
receptor I
kinases I
implicated O
in O
the O
rejection O
of O
self O
- O
pollen O
in O
Brassica O
species O
and O
the O
Pto B
gene I
product I
of I
tomato I
which O
confers O
resistance O
to O
a O
bacterial O
pathogen O
. O

Null O
alleles O
of O
SAS4 B
and O
SAS5 B
bypassed O
the O
role O
of O
the O
Abf1p B
binding I
site I
of O
the O
HMR B
- I
E I
silencer I
but O
not O
the O
role O
of O
the O
ACS B
or O
Rap1p B
binding I
site I
. O

Precipitation O
using O
GST B
fusion I
proteins I
containing O
Fyn B
SH2 B
, O
SH3 B
, O
and O
SH2 B
/ O
SH3 B
domains O
revealed O
that O
PI B
3 I
- I
kinase I
bound O
principally O
to O
the O
SH3 B
domain I
of O
Fyn B
. O

Binding O
of O
U2 B
small I
nuclear I
ribonucleoprotein I
( O
snRNP O
) O
to O
the O
pre O
- O
mRNA O
is O
an O
early O
and O
important O
step O
in O
spliceosome O
assembly O
. O

Mss4 B
also O
acts O
as O
a O
relatively O
inefficient O
guanine B
nucleotide I
exchange I
factor I
( O
GEF B
) O
. O

Here O
, O
we O
identify O
Rsc3 B
and O
Rsc30 B
as O
novel O
components O
of O
the O
essential O
yeast B
remodeler I
RSC I
complex I
. O

Possibly O
, O
the O
scr1 B
- I
1 I
mutation I
does O
not O
affect O
signal O
recognition O
or O
translational O
arrest O
but O
instead O
results O
in O
maintenance O
of O
translational O
arrest O
of O
AEP B
synthesis O
. O

Sequence O
analysis O
of O
the O
sMtCK B
genomic I
upstream I
sequences I
reveals O
a O
typical O
TATAA O
box O
within O
the O
80 O
base O
pairs O
( O
bp O
) O
that O
, O
by O
transfection O
experiments O
, O
are O
sufficient O
to O
promote O
expression O
of O
chimeric O
plasmids O
with O
the O
chloramphenicol B
acetyltransferase I
reporter I
. O

Sequence O
analysis O
of O
the O
sMtCK B
genomic I
upstream I
sequences I
reveals O
a O
typical O
TATAA O
box O
within O
the O
80 O
base O
pairs O
( O
bp O
) O
that O
, O
by O
transfection O
experiments O
, O
are O
sufficient O
to O
promote O
expression O
of O
chimeric O
plasmids O
with O
the O
chloramphenicol B
acetyltransferase I
reporter I
. O

Zebrafish O
cyclops B
( O
cyc B
) O
encodes O
a O
Transforming B
Growth I
Factor I
beta I
( O
TGFbeta B
) O
signaling O
factor O
closely O
related O
to O
mouse O
Nodal B
. O

Characterization O
of O
the O
microtubule O
binding O
domain O
of O
microtubule B
actin I
crosslinking I
factor I
( O
MACF B
) O
: O
identification O
of O
a O
novel O
group O
of O
microtubule B
associated I
proteins I
. O

Our O
results O
indicate O
that O
the O
KRAB B
domain I
present O
in O
the O
non O
- O
finger O
region O
of O
many O
ZFP B
genes I
quenches O
transcription O
possibly O
due O
to O
specific O
protein O
- O
protein O
interactions O
between O
the O
KRAB B
- I
A I
domain I
and O
components O
of O
the O
proximal O
transcriptional O
apparatus O
. O

Structure O
and O
expression O
of O
the O
mouse B
growth I
hormone I
receptor I
/ O
growth B
hormone I
binding I
protein I
gene I
. O

Novel O
intronic O
promoter O
in O
the O
rat B
ER I
alpha I
gene I
responsible O
for O
the O
transient O
transcription O
of O
a O
variant O
receptor O
. O

In O
order O
to O
define O
potential O
candidate O
genes O
for O
inherited O
disorders O
characterized O
by O
aberrant O
gene O
expression O
, O
we O
utilized O
Kruppel B
- I
related I
sequences I
to O
isolate O
zinc O
finger O
- O
containing O
cDNAs O
. O

Dopamine B
beta I
- I
hydroxylase I
( O
DBH B
) O
catalyzes O
the O
conversion O
of O
dopamine O
to O
noradrenaline O
and O
is O
selectively O
expressed O
in O
noradrenergic O
and O
adrenergic O
neurons O
and O
neuroendocrine O
cells O
. O

Pitx2 B
rescues O
the O
GABAergic O
differentiation O
defect O
and O
partially O
rescues O
the O
axon O
guidance O
and O
behavioral O
phenotypes O
of O
unc B
- I
30 I
mutants I
, O
indicating O
a O
high O
degree O
of O
functional O
conservation O
between O
these O
evolutionarily O
related O
genes O
. O

The O
normal O
cell O
cycle O
is O
regulated O
by O
several O
molecules O
, O
such O
as O
the O
tumor B
- I
suppressor I
protein I
pRb I
, O
the O
G1 B
cyclins I
, O
the O
cyclin B
- I
dependent I
kinases I
, O
and O
their O
inhibitors O
. O

Phosphorylation O
of O
myosin B
- I
binding I
subunit I
( O
MBS B
) O
of O
myosin B
phosphatase I
by O
Rho B
- I
kinase I
in O
vivo O
. O

Such O
an O
increase O
in O
the O
steady O
- O
state O
testicular B
TIMP I
- I
2 I
mRNA I
level O
apparently O
is O
not O
the O
result O
of O
an O
up O
- O
regulation O
by O
germ O
cells O
because O
germ O
cells O
cocultured O
with O
Sertoli O
cells O
failed O
to O
elicit O
an O
increase O
in O
the O
Sertoli O
cell O
steady O
- O
state O
TIMP B
- I
2 I
mRNA I
level O
. O

The O
Cili B
- I
2 I
sequences I
possess O
similarity O
to O
the O
RNaseH B
domain I
of O
Lian B
- O
Aa1 B
, O
a O
mosquito B
non I
- I
LTR I
retrotransposon I
. O

Among O
these O
360 O
ZFPs B
, O
a O
novel O
ZFP B
cDNA I
named O
HFHZ B
( O
human B
fetal I
heart I
ZFP I
) O
with O
sequence O
homology O
to O
a O
Kruppel B
- I
associated I
box I
( O
KRAB B
) O
was O
identified O
. O

Among O
these O
360 O
ZFPs B
, O
a O
novel O
ZFP B
cDNA I
named O
HFHZ B
( O
human B
fetal I
heart I
ZFP I
) O
with O
sequence O
homology O
to O
a O
Kruppel B
- I
associated I
box I
( O
KRAB B
) O
was O
identified O
. O

They O
also O
negatively O
modulate O
the O
PI B
3 I
- I
kinase I
catalytic O
activity O
but O
to O
different O
extents O
, O
dependent O
on O
the O
unique O
N O
- O
terminal O
structure O
of O
each O
isoform O
. O

In O
acute O
- O
phase O
livers O
, O
we O
observed O
a O
dramatic O
reduction O
in O
HNF B
- I
3 I
alpha I
expression O
which O
correlates O
with O
a O
decrease O
in O
the O
expression O
of O
its O
target O
gene O
, O
the O
TTR B
gene I
. O

Sequence O
analysis O
revealed O
that O
the O
MEMA B
protein I
is O
identical O
with O
a O
160 B
kDa I
nuclear I
' I
domain I
rich I
in I
serines I
' I
( I
DRS I
) I
protein I
occurring O
free O
in O
the O
nucleoplasm O
and O
in O
U2 B
- I
ribonucleoprotein I
structures I
. O

Value O
of O
the O
method O
of O
passive O
hemagglutination O
with O
polysaccharide O
C O
in O
detecting O
C B
- I
reactive I
protein I
as O
compared O
to O
precipitation O
in O
capillaries O
and O
slide O
latex O
test O
with O
anti B
- I
CRP I
serum O

Human B
LAF I
- I
4 I
readily O
hybridized O
with O
genes O
in O
mouse O
and O
chicken O
, O
thus O
showing O
that O
this O
gene O
family O
has O
been O
highly O
conserved O
during O
vertebrate O
evolution O
. O

This O
regulation O
requires O
two O
HMG B
- I
box I
proteins I
: O
the O
ubiquitous O
Ste11 B
transcription I
factor I
and O
the O
M O
cell O
- O
controlling O
protein O
Mat1 B
- I
Mc I
. O

Upon O
tyrosine O
phosphorylation O
at O
the O
ITIMs O
, O
these O
molecules O
recruit O
SH2 B
domain O
- O
containing O
phosphatases O
such O
as O
SH2 B
- O
containing O
tyrosine B
phosphatase I
- I
1 I
and O
negatively O
regulate O
cell O
activity O
. O

The O
promoter O
for O
HMG B
- I
CoA I
synthase I
contains O
two O
binding O
sites O
for O
the O
sterol B
regulatory I
element I
- I
binding I
proteins I
( O
SREBPs B
) O
. O

Transactivation O
of O
oIFNtau B
enhancer O
- O
reporter O
constructs O
was O
primarily O
regulated O
by O
three O
regions O
containing O
AP B
- I
1 I
site I
, O
GATA B
like I
sequence I
and O
site O
( O
s O
) O
unidentified O
. O

One O
of O
these O
elements O
, O
the O
homeodomain B
- I
binding I
element I
, O
was O
identified O
to O
mediate O
negative O
regulation O
. O

These O
data O
should O
be O
useful O
in O
developing O
reagents O
for O
heterozygote O
detection O
and O
prenatal O
diagnosis O
of O
11 B
beta I
- I
hydroxylase I
deficiency O
, O
the O
second O
most O
frequent O
cause O
of O
congenital O
adrenal O
hyperplasia O
. O

In O
our O
studies O
, O
we O
utilized O
HIV O
- O
1 O
HXB2 B
and O
HIV O
- O
1 O
Z2Z6 B
core I
enhancers I
because O
the O
Z2Z6 B
strain O
has O
a O
single O
point O
mutation O
flanking O
the O
right O
ETS B
- I
binding I
site I
. O

Platelet B
- I
derived I
growth I
factor I
- O
dependent O
activation O
of O
phosphatidylinositol B
3 I
- I
kinase I
is O
regulated O
by O
receptor O
binding O
of O
SH2 B
- I
domain I
- I
containing I
proteins I
which O
influence O
Ras B
activity O
. O

Relatively O
large O
DNA O
rearrangements O
spanning O
the O
region O
with O
tandem O
direct O
repeats O
encoding O
the O
carboxy O
- O
terminal O
histone B
H1 I
- I
like I
structure O
of O
AlgP B
were O
detected O
in O
several O
strains O
upon O
conversion O
from O
the O
mucoid O
to O
the O
nonmucoid O
phenotype O
. O

Kaposi O
' O
s O
sarcoma O
- O
associated O
herpesvirus O
viral B
interferon I
regulatory I
factor I
confers O
resistance O
to O
the O
antiproliferative O
effect O
of O
interferon B
- I
alpha I
. O

Identification O
of O
a O
consensus O
cyclin B
- I
dependent I
kinase I
phosphorylation I
site I
unique O
to O
the O
nuclear O
form O
of O
human B
deoxyuridine I
triphosphate I
nucleotidohydrolase I
. O

Topological O
and O
mutational O
analysis O
of O
Saccharomyces B
cerevisiae I
Ste14p I
, O
founding O
member O
of O
the O
isoprenylcysteine B
carboxyl I
methyltransferase I
family I
. O

Fowlpox O
virus O
encodes O
nonessential O
homologs O
of O
cellular B
alpha I
- I
SNAP I
, O
PC B
- I
1 I
, O
and O
an O
orphan O
human O
homolog O
of O
a O
secreted O
nematode O
protein O
. O

A O
chicken B
paxillin I
cDNA I
was O
also O
cloned O
and O
is O
predicted O
to O
encode O
a O
protein O
approximately O
90 O
% O
identical O
to O
human B
paxil I
- I
lin I
. O

Identification O
of O
mutations O
in O
the O
coding O
sequence O
of O
the O
proto B
- I
oncogene I
c I
- I
kit I
in O
a O
human O
mast O
cell O
leukemia O
cell O
line O
causing O
ligand O
- O
independent O
activation O
of O
c B
- I
kit I
product I
. O

The O
regulation O
of O
PGHS B
- I
2 I
mRNA I
and O
protein O
was O
studied O
in O
primary O
cultures O
of O
bovine O
uterine O
stromal O
cells O
stimulated O
with O
phorbol O
12 O
- O
myristate O
13 O
- O
acetate O
( O
PMA O
; O
100 O
nM O
) O
. O

We O
concluded O
that O
activation O
of O
c B
- I
fosER I
mediated O
transcriptional O
inhibition O
of O
p21 B
( O
Cip1 B
/ O
WAF1 B
) O
through O
a O
previously O
uncharacterized O
AP B
- I
1 I
site I
, O
revealing O
an O
important O
role O
for O
c B
- I
fos I
in O
negative O
control O
of O
cell O
cycle O
regulatory O
genes O
. O

The O
above O
results O
mean O
that O
the O
increase O
in O
alpha B
- I
adrenergic I
receptors I
makes O
the O
prostate O
, O
which O
has O
been O
already O
hypertrophied O
, O
less O
elastic O
, O
inhibiting O
external O
urinary O
sphincter O
function O
. O

Plasmids O
were O
constructed O
with O
the O
mouse O
promoter O
region O
linked O
to O
the O
reporter B
gene I
chloramphenicol I
acetyltransferase I
( O
CAT B
) O
, O
and O
transiently O
and O
stably O
transfected O
in O
the O
INS O
- O
1 O
cells O
. O

A O
contiguous O
and O
sequentially O
occupied O
secondary O
Fur B
- I
binding I
site I
in O
entC B
was O
protected O
at O
higher O
Fur B
concentrations O
, O
extending O
the O
protected O
region O
to O
+ O
49 O
, O
and O
sequestering O
the O
putative O
Shine O
- O
Dalgarno O
sequence O
. O

The O
evidence O
in O
support O
of O
this O
was O
derived O
from O
the O
fact O
that O
the O
affinity O
or O
interaction O
between O
the O
two O
subunits O
was O
impaired O
as O
indicated O
by O
the O
first O
order O
rate O
constant O
of O
hCG B
alpha I
1 I
beta I
( O
km O
= O
4 O
. O
1 O
x O
10 O
( O
- O
2 O
) O
min O
- O
1 O
) O
at O
pH O
3 O
. O
0 O
at O
23 O
degrees O
C O
which O
is O
one O
order O
of O
magnitude O
greater O
relative O
to O
rehCG B
( O
kw O
= O
4 O
. O
6 O
x O
10 O
( O
- O
3 O
) O
min O
- O
1 O
) O
. O

Analysis O
of O
promoter O
and O
androgen O
regulatory O
sequences O
required O
for O
optimal O
transcription O
of O
the O
rat O
androgen B
- I
binding I
protein I
gene O
. O

C B
/ I
EBPbeta I
LIP I
overexpressing O
HC11 O
cells O
did O
not O
express O
beta B
- I
casein I
mRNA I
( O
mammary O
epithelial O
cell O
differentiation O
marker O
) O
in O
response O
to O
lactogenic O
hormones O
. O

C B
/ I
EBPbeta I
LIP I
overexpressing O
HC11 O
cells O
did O
not O
express O
beta B
- I
casein I
mRNA I
( O
mammary O
epithelial O
cell O
differentiation O
marker O
) O
in O
response O
to O
lactogenic O
hormones O
. O

C B
/ I
EBP I
alpha I
also O
activates O
the O
promoter O
of O
the O
rat B
class I
- I
I I
ADH I
gene I
in O
a O
sequence O
- O
specific O
manner O
[ O
Potter O
et O
al O
. O
, O
Arch O
. O

C B
/ I
EBP I
alpha I
also O
activates O
the O
promoter O
of O
the O
rat B
class I
- I
I I
ADH I
gene I
in O
a O
sequence O
- O
specific O
manner O
[ O
Potter O
et O
al O
. O
, O
Arch O
. O

Our O
results O
confirm O
the O
participation O
of O
intron O
1 O
in O
transcriptional O
regulation O
of O
the O
c B
- I
myb I
gene I
( O
in O
mouse O
and O
human O
) O
and O
implicate O
multiple O
and O
complex O
regulatory O
mechanisms O
of O
activation O
during O
myelomonocytic O
differentiation O
and O
leukemic O
cell O
growth O
control O
. O

This O
TC B
- I
II I
enhanson I
, O
which O
is O
identical O
to O
the O
kappa B
B I
motif I
from O
the O
kappa B
chain I
enhancer I
, O
was O
active O
in O
both O
lymphoid O
and O
non O
- O
lymphoid O
cells O
, O
which O
contrasts O
with O
the O
previously O
reported O
lymphoid O
cell O
specificity O
of O
the O
kappa B
B I
motif I
. O

Mutations O
in O
the O
nuclear B
gene I
CBP1 I
of I
Saccharomyces I
cerevisiae I
result O
in O
degradation O
of O
mitochondrially B
encoded I
cytochrome I
b I
( O
cob B
) O
RNA O
; O
thus O
, O
the O
cells O
are O
unable O
to O
respire O
. O

Plasma B
secretin I
, O
pancreozymin B
, O
and O
somatostatin B
- I
like I
hormone I
in O
chronic O
renal O
failure O
patients O
. O

DNase B
I I
genomic O
footprinting O
revealed O
that O
the O
c B
- I
Myb I
site I
is O
occupied O
in O
a O
tissue O
- O
specific O
fashion O
in O
vivo O
. O

The O
U17 B
/ O
U16 B
and O
the O
U16 B
+ I
gene I
products I
transactivated O
the O
HIV B
LTR I
. O

We O
describe O
a O
novel O
cytoplasmic B
tyrosine I
kinase I
, O
termed O
BPK B
( O
B B
cell I
progenitor I
kinase I
) O
, O
which O
is O
expressed O
in O
all O
stages O
of O
the O
B O
lineage O
and O
in O
myeloid O
cells O
. O

PATIENTS O
AND O
METHODS O
: O
We O
report O
our O
experience O
with O
seven O
children O
with O
active O
small O
bowel O
Crohn O
' O
s O
disease O
given O
a O
casein B
- O
based O
, O
polymeric O
feed O
rich O
in O
TGF B
- I
beta I
2 I
( O
Specific O
Polymeric O
Diet O
; O
Nestle O
- O
Clintec O
; O
Vevey O
, O
Switzerland O
) O
as O
complete O
nutrition O
for O
8 O
weeks O
. O

Neither O
mutant O
exhibited O
derepression O
of O
the O
silent B
mating I
type I
loci I
. O

Mouse B
growth I
hormone I
transcription I
factor I
Zn I
- I
16 I
: O
unique O
bipartite O
structure O
containing O
tandemly O
repeated O
zinc O
finger O
domains O
not O
reported O
in O
rat B
Zn I
- I
15 I
. O

Unexpectedly O
, O
all O
ENK B
- I
specific I
motifs I
formed O
specific O
and O
highly O
abundant O
protein O
- O
DNA O
complexes O
when O
nuclear O
extracts O
from O
the O
human O
tumor O
cell O
line O
( O
HeLa O
) O
, O
which O
does O
not O
express O
ENK B
, O
were O
used O
. O

We O
have O
attempted O
to O
clone O
two O
recessive O
extragenic O
suppressors O
of O
such O
ts O
mutants O
( O
sdp1 B
for O
mutation B
pol3 I
- I
14 I
and O
sdp5 B
- I
1 I
for O
mutation B
pol3 I
- I
11 I
) O
by O
transforming O
thermoresistant O
haploid O
strains O
pol3 B
- I
14 I
sdp1 I
and O
pol3 B
- I
11 I
sdp5 I
- I
1 I
with O
wild O
- O
type O
genomic O
libraries O
in O
singlecopy O
or O
multicopy O
vectors O
. O

We O
have O
attempted O
to O
clone O
two O
recessive O
extragenic O
suppressors O
of O
such O
ts O
mutants O
( O
sdp1 B
for O
mutation B
pol3 I
- I
14 I
and O
sdp5 B
- I
1 I
for O
mutation B
pol3 I
- I
11 I
) O
by O
transforming O
thermoresistant O
haploid O
strains O
pol3 B
- I
14 I
sdp1 I
and O
pol3 B
- I
11 I
sdp5 I
- I
1 I
with O
wild O
- O
type O
genomic O
libraries O
in O
singlecopy O
or O
multicopy O
vectors O
. O

We O
have O
attempted O
to O
clone O
two O
recessive O
extragenic O
suppressors O
of O
such O
ts O
mutants O
( O
sdp1 B
for O
mutation B
pol3 I
- I
14 I
and O
sdp5 B
- I
1 I
for O
mutation B
pol3 I
- I
11 I
) O
by O
transforming O
thermoresistant O
haploid O
strains O
pol3 B
- I
14 I
sdp1 I
and O
pol3 B
- I
11 I
sdp5 I
- I
1 I
with O
wild O
- O
type O
genomic O
libraries O
in O
singlecopy O
or O
multicopy O
vectors O
. O

Derivation O
and O
initial O
characterization O
of O
a O
mouse O
mammary O
tumor O
cell O
line O
carrying O
the O
polyomavirus B
middle I
T I
antigen I
: O
utility O
in O
the O
development O
of O
novel O
cancer O
therapeutics O
. O

On O
the O
other O
hand O
, O
the O
structures O
of O
the O
b O
- O
Zip O
domain O
are O
well O
conserved O
among O
these O
Maf B
- I
related I
proteins I
. O

The O
gene O
encoding O
the O
receptor O
for O
macrophage B
colony I
- I
stimulating I
factor I
1 I
( O
CSF B
- I
1 I
) O
, O
the O
c B
- I
fms I
protooncogene I
, O
is O
selectively O
expressed O
in O
immature O
and O
mature O
mononuclear O
phagocytes O
and O
trophoblasts O
. O

The O
observed O
phenotypes O
may O
be O
explained O
by O
( O
i O
) O
a O
selective O
disruption O
of O
very B
- I
low I
- I
density I
lipoprotein I
secretion O
due O
to O
decreased O
expression O
of O
genes O
encoding O
apolipoprotein B
B I
and O
microsomal B
triglyceride I
transfer I
protein I
, O
( O
ii O
) O
an O
increase O
in O
hepatic O
cholesterol O
uptake O
due O
to O
increased O
expression O
of O
the O
major O
high B
- I
density I
lipoprotein I
receptor I
, O
scavenger B
receptor I
BI I
, O
and O
( O
iii O
) O
a O
decrease O
in O
bile O
acid O
uptake O
to O
the O
liver O
due O
to O
down O
- O
regulation O
of O
the O
major O
basolateral B
bile I
acid I
transporters I
sodium I

Relatively O
little O
is O
known O
regarding O
the O
role O
of O
5 B
- I
HT2 I
receptor I
activity O
in O
male O
rat O
sexual O
behavior O
. O

TNF B
Treatment O
of O
cell O
activated O
the O
p38 B
MAP I
kinase I
pathway O
, O
as O
revealed O
by O
increased O
phosphorylation O
of O
p38 B
MAP I
kinase I
itself O
, O
activation O
of O
the O
substrate O
protein O
MAPKAP B
kinase I
- I
2 I
, O
and O
culminating O
in O
the O
phosphorylation O
of O
the O
heat B
shock I
protein I
27 I
( O
hsp27 B
) O
. O

TNF B
Treatment O
of O
cell O
activated O
the O
p38 B
MAP I
kinase I
pathway O
, O
as O
revealed O
by O
increased O
phosphorylation O
of O
p38 B
MAP I
kinase I
itself O
, O
activation O
of O
the O
substrate O
protein O
MAPKAP B
kinase I
- I
2 I
, O
and O
culminating O
in O
the O
phosphorylation O
of O
the O
heat B
shock I
protein I
27 I
( O
hsp27 B
) O
. O

NF B
- I
kappa I
B I
/ O
Rel B
transcription O
factors O
participate O
in O
the O
activation O
of O
numerous O
genes O
involved O
in O
immune O
regulation O
/ O
inflammation O
including O
cytokines O
, O
cell O
surface O
receptors O
, O
adhesion O
molecules O
, O
and O
acute O
phase O
proteins O
. O

The O
Drosophila B
melanogaster I
suppressor I
of I
sable I
gene I
, O
su B
( I
s I
) I
, O
encodes O
a O
novel O
, O
150 O
- O
kDa O
nuclear O
RNA O
binding O
protein O
, O
SU B
( I
S I
) I
, O
that O
negatively O
regulates O
RNA O
accumulation O
from O
mutant O
alleles O
of O
other O
genes O
that O
have O
transposon O
insertions O
in O
the O
5 O
' O
transcribed O
region O
. O

The O
Drosophila B
melanogaster I
suppressor I
of I
sable I
gene I
, O
su B
( I
s I
) I
, O
encodes O
a O
novel O
, O
150 O
- O
kDa O
nuclear O
RNA O
binding O
protein O
, O
SU B
( I
S I
) I
, O
that O
negatively O
regulates O
RNA O
accumulation O
from O
mutant O
alleles O
of O
other O
genes O
that O
have O
transposon O
insertions O
in O
the O
5 O
' O
transcribed O
region O
. O

The O
promoter O
was O
stimulated O
8 O
- O
20 O
- O
fold O
by O
phorbol O
esters O
accounting O
for O
the O
previously O
observed O
transcriptional O
activation O
of O
protein B
kinase I
C I
beta I
. O

Taken O
together O
, O
these O
results O
indicate O
that O
MAP B
kinase I
stimulates O
the O
hPL B
- I
B I
enhancer I
by O
an O
NF B
- I
IL I
- I
6 I
- O
dependent O
pathway O
. O

The O
discussion O
focuses O
primarily O
on O
the O
newer O
drugs O
like O
angiotensin B
converting I
enzyme I
inhibitors O
, O
alpha B
- I
adrenergic I
receptor I
blockers O
, O
and O
calcium O
antagonists O
. O

Effect O
of O
castration O
on O
pituitary B
and I
serum I
LH I
and O
FSH B
in O
testosterone O
- O
sterilized O
rats O
. O

The O
84 B
. I
1C I
mAb I
recognizes O
a O
site O
on O
IgE B
which O
is O
identical O
or O
very O
close O
to O
the O
Fc B
epsilon I
R I
binding I
site I
, O
and O
95 O
. O
3 O
recognizes O
a O
site O
on O
IgE B
which O
is O
related O
, O
but O
not O
identical O
to O
the O
Fc B
epsilon I
R I
binding I
site I
. O

A O
second O
important O
molecule O
in O
TCR B
signal O
transduction O
is O
the O
guanine B
nucleotide I
binding I
protein I
, O
p21ras B
, O
which O
is O
coupled O
to O
the O
TCR B
by O
a O
protein B
tyrosine I
kinase I
dependent O
mechanism O
. O

However O
, O
while O
the O
sequence O
similarity O
between O
the O
membrane O
exons O
of O
avian B
mIgY I
and O
mammalian B
mIgG I
and I
IgE I
is O
striking O
, O
the O
overall O
similarity O
with O
Xenopus B
mIgY I
is O
very O
low O
. O

We O
conclude O
that O
the O
alpha O
- O
subunit O
of O
the O
telomere B
- I
binding I
protein I
, O
like O
many O
transcription O
factors O
, O
has O
separable O
DNA O
- O
binding O
and O
protein O
- O
protein O
interaction O
domains O
. O

A O
subset O
of O
these O
DMP1 B
recognition I
sequences I
containing O
a O
GGA O
trinucleotide O
core O
can O
also O
function O
as O
Ets B
- I
responsive I
elements I
. O

A O
large O
deletion O
in O
the O
CTD B
- I
binding I
motif I
blocks O
down O
- O
regulation O
but O
does O
not O
affect O
the O
essential O
function O
of O
Nrd1 B
. O

Anti B
- I
CRK I
antibodies I
detect O
a O
53kDa O
protein O
in O
extracts O
of O
C O
. O
fasciculata O
in O
agreement O
with O
the O
size O
predicted O
from O
the O
nucleotide O
sequence O
of O
the O
cloned O
gene O
. O

A O
particularly O
striking O
HpaII B
tiny O
fragment O
island O
, O
extending O
over O
nearly O
2 O
, O
000 O
base O
pairs O
, O
surrounds O
the O
USF2 B
translation I
initiation I
site I
. O

Comparisons O
with O
other O
known O
germins B
and O
germin B
- I
like I
proteins I
indicate O
that O
these O
Arabidopsis O
GLP B
subfamilies O
are O
unique O
from O
wheat O
germin B
. O

The O
previously O
described O
enhanced O
translation O
of O
spinach O
L12 B
mRNA I
from O
its O
two O
tandem O
AUG O
codons O
and O
the O
two O
functional O
rpl12 B
genes I
in O
Arabidopsis O
probably O
provide O
two O
mechanisms O
for O
generating O
the O
four O
copies O
of O
L12 B
/ I
chloroplast I
ribosome I
, O
qualitatively O
different O
from O
those O
attempted O
in O
eubacteria O
. O

Nucleotide O
sequence O
analysis O
revealed O
that O
TAR B
- I
binding I
protein I
is O
very O
similar O
to O
the O
CREB2 B
protein I
. O

The O
frequency O
of O
positive O
anti B
- I
GM1 I
antibody I
titers O
in O
the O
Guillain O
- O
Barre O
syndrome O
patients O
with O
PEN O
19 O
isolates O
was O
higher O
than O
that O
in O
the O
Guillain O
- O
Barre O
syndrome O
and O
Fisher O
' O
s O
syndrome O
patients O
without O
PEN O
19 O
isolates O
. O

TBP B
can O
be O
phosphorylated O
in O
vitro O
by O
extracts O
of O
U937 O
cells O
or O
by O
bacterially O
expressed O
activated O
ERK2 B
; O
the O
phosphorylation O
sites O
were O
mapped O
to O
ERK B
kinase I
consensus I
sites I
in O
the O
TBP B
amino I
- I
terminal I
domain I
. O

However O
, O
by O
an O
NS35 B
- I
specific I
RNA I
capture O
assay O
, O
the O
multimers O
were O
shown O
to O
possess O
the O
RNA O
- O
binding O
activity O
previously O
demonstrated O
for O
NS35 B
. O

We O
demonstrate O
here O
that O
the O
- O
DEDDDL O
sequence O
stabilizes O
GDP O
binding O
to O
Ran B
, O
and O
that O
the O
domain O
is O
required O
for O
high O
affinity O
interaction O
with O
a O
Ran B
- I
binding I
protein I
, O
HTF9A B
/ O
RanBP1 B
. O

The O
RNase B
MRP I
RNA I
gene I
was O
deleted O
by O
insertional O
replacement O
and O
found O
to O
be O
essential O
for O
cellular O
viability O
, O
indicating O
a O
critical O
nuclear O
role O
for O
RNase B
MRP I
. O

Isolation O
by O
PCR O
of O
a O
cDNA O
clone O
from O
pea O
petals O
with O
similarity O
to O
petunia O
and O
wheat B
zinc I
finger I
proteins I
. O

Sterile O
mutants O
of O
Saccharomyces O
cerevisiae O
were O
isolated O
from O
alpha O
* O
cells O
having O
the O
a B
/ I
alpha I
aar1 I
- I
6 I
genotype O
( O
exhibiting O
alpha O
mating O
ability O
and O
weak O
a O
mating O
ability O
as O
a O
result O
of O
a O
defect O
in O
a1 B
- I
alpha I
2 I
repression O
) O
. O

Leukemia B
- I
inhibitory I
factor I
( O
LIF B
) O
is O
a O
neuropoietin B
able O
to O
regulate O
the O
differentiation O
and O
the O
survival O
of O
many O
cell O
types O
, O
which O
include O
some O
neuronal O
populations O
. O

When O
ligated O
to O
the O
proIL B
- I
1 I
beta I
cap I
site I
- I
proximal I
region I
( O
located O
between O
- O
131 O
to O
+ O
12 O
) O
, O
both O
the O
proIL B
- I
1 I
beta I
and O
the O
simian B
virus I
40 I
enhancer I
elements I
functioned O
more O
efficiently O
in O
monocytes O
than O
in O
HeLa O
cells O
, O
which O
are O
not O
normally O
competent O
for O
IL B
- I
1 I
beta I
expression O
. O

When O
ligated O
to O
the O
proIL B
- I
1 I
beta I
cap I
site I
- I
proximal I
region I
( O
located O
between O
- O
131 O
to O
+ O
12 O
) O
, O
both O
the O
proIL B
- I
1 I
beta I
and O
the O
simian B
virus I
40 I
enhancer I
elements I
functioned O
more O
efficiently O
in O
monocytes O
than O
in O
HeLa O
cells O
, O
which O
are O
not O
normally O
competent O
for O
IL B
- I
1 I
beta I
expression O
. O

Molecular O
cloning O
and O
expression O
of O
human B
UDP I
- I
d I
- I
Xylose I
: I
proteoglycan I
core I
protein I
beta B
- I
d I
- I
xylosyltransferase I
and O
its O
first O
isoform B
XT I
- I
II I
. O

Expression O
of O
lacZ B
from O
the O
promoter O
of O
the O
Escherichia B
coli I
spc I
operon I
cloned O
into O
vectors O
carrying O
the O
W205 O
trp B
- O
lac B
fusion O
. O

We O
have O
now O
tested O
all O
known O
mammalian B
Groucho I
family I
members I
for O
their O
ability O
to O
interact O
specifically O
with O
individual O
Tcf B
/ O
Lef B
family O
members O
. O

This O
revealed O
a O
minimum O
of O
six O
novel O
OSBP B
- I
related I
proteins I
, O
designated O
ORP B
- I
1 I
to O
ORP B
- I
6 I
. O

To O
understand O
whether O
Shc B
localization O
in O
membrane O
rafts O
is O
sufficient O
to O
regulate O
Shc B
function O
, O
we O
constructed O
a O
Shc B
chimera I
containing O
the O
Ras B
membrane I
localization I
motif I
at O
the O
C O
- O
terminus O
. O

A O
general O
model O
for O
ARE O
- O
mediated O
mRNA O
degradation O
involving O
a O
potential O
role O
for O
certain O
heterogeneous O
nuclear O
ribonucleoproteins O
and O
ARE B
- I
binding I
proteins I
is O
proposed O
. O

The O
previously O
described O
four O
sets O
of O
13 O
- O
to O
18 O
- O
base O
- O
pair O
interspersed O
repeat O
elements O
between O
- O
55 O
and O
- O
580 O
provide O
most O
of O
the O
high O
basal O
transcriptional O
strength O
, O
whereas O
the O
arrangement O
of O
further O
upstream O
tandemly O
repeated O
NF1 B
- I
binding I
sites I
may O
contribute O
significantly O
to O
the O
expanded O
biological O
host O
range O
for O
expression O
of O
SCMV B
IE94 I
compared O
with O
HCMV B
IE68 I
. O

Overexpression O
of O
wild B
- I
type I
p53 I
also O
induces O
apoptosis O
in O
an O
LCL O
. O

Unlike O
wild B
- I
type I
p53 I
, O
the O
delta B
proAE I
mutant I
cDNA I
can O
be O
stably O
expressed O
in O
tumor O
derived O
cell O
lines O
with O
few O
immediate O
detrimental O
effects O
. O

Unlike O
wild B
- I
type I
p53 I
, O
the O
delta B
proAE I
mutant I
cDNA I
can O
be O
stably O
expressed O
in O
tumor O
derived O
cell O
lines O
with O
few O
immediate O
detrimental O
effects O
. O

Identical O
c B
- I
erbB3 I
transcripts I
are O
expressed O
in O
normal O
human O
placental O
tissues O
. O

We O
also O
show O
that O
activation O
of O
protein B
kinase I
A I
( O
PKA B
) O
signaling O
is O
sufficient O
to O
down O
- O
regulate O
caveolin B
- I
1 I
protein I
expression O
and O
promoter O
activity O
. O

Cloning O
of O
a O
human O
cDNA O
encoding O
a O
CDC2 B
- I
related I
kinase I
by O
complementation O
of O
a O
budding B
yeast I
cdc28 I
mutation O
. O

Using O
mutagenesis O
, O
we O
have O
identified O
two O
mutations O
of O
the O
second O
actin B
- I
binding I
domain I
that O
can O
also O
suppress O
the O
act1 B
mutations O
of O
interest O
. O

Finally O
, O
antibody O
binding O
to O
site O
IIIa O
on O
the O
hCG B
- I
ectodomain I
complex I
was O
also O
hindered O
by O
an O
anti O
- O
peptide O
mAb O
directed O
against O
a O
peptide O
encoded O
by O
the O
eighth O
exon O
( O
pE O
x O
8 O
) O
of O
the O
LHR B
. O

Recently O
, O
an O
alternatively O
spliced O
form O
of O
c B
- I
myb I
- I
encoded I
mRNA I
has O
been O
identified O
in O
murine O
cells O
containing O
either O
normal O
or O
rearranged O
c B
- I
myb I
genes I
. O

Northern O
( O
RNA O
) O
analysis O
demonstrated O
expression O
of O
human O
PI B
3 I
- I
kinase I
in O
all O
tissues O
and O
cell O
lines O
tested O
. O

Our O
data O
demonstrate O
directly O
that O
Rpm1r B
is O
transcribed O
with O
its O
substrates O
, O
tRNA B
met I
f I
and O
tRNAPro B
, O
from O
a O
promoter O
located O
upstream O
of O
the O
tRNA B
met I
f I
gene I
and O
suggest O
that O
a O
portion O
also O
originates O
from O
a O
second O
promoter O
, O
located O
between O
the O
tRNA B
met I
f I
gene I
and O
RPM1 B
. O

Our O
data O
demonstrate O
directly O
that O
Rpm1r B
is O
transcribed O
with O
its O
substrates O
, O
tRNA B
met I
f I
and O
tRNAPro B
, O
from O
a O
promoter O
located O
upstream O
of O
the O
tRNA B
met I
f I
gene I
and O
suggest O
that O
a O
portion O
also O
originates O
from O
a O
second O
promoter O
, O
located O
between O
the O
tRNA B
met I
f I
gene I
and O
RPM1 B
. O

In O
the O
present O
study O
, O
we O
have O
isolated O
and O
sequenced O
several O
p15E B
cDNA I
gene I
fragments I
amplified O
by O
means O
of O
polymerase O
chain O
reaction O
( O
PCR O
) O
from O
parental O
( O
P815 O
) O
and O
xenogenized O
( O
P815 O
/ O
DTIC O
) O
tumour O
cells O
. O

Lysine B
- I
ketoglutarate I
reductase I
and O
saccharopine B
dehydrogenase I
from O
Arabidopsis O
thaliana O
: O
nucleotide O
sequence O
and O
characterization O
. O

The O
data O
indicate O
that O
etr B
- I
1 I
is O
essential O
for O
muscle O
development O
in O
C O
. O
elegans O
, O
perhaps O
by O
playing O
a O
role O
in O
post O
- O
transcriptional O
processing O
of O
some O
muscle O
component O
, O
and O
thus O
suggesting O
a O
possible O
conservation O
of O
gene O
function O
with O
human B
CUG I
- I
bp I
. O

O B
. I
novo I
- I
ulmi I
RNA I
- I
7 I
, O
previously O
believed O
to O
be O
a O
satellite O
- O
like O
RNA O
, O
is O
shown O
to O
be O
a O
defective O
RNA O
, O
derived O
from O
OnuMV4 B
- I
Ld I
RNA I
by O
multiple O
internal O
deletions O
. O

Examination O
of O
immediate B
- I
early I
transcription I
factor I
expression O
during O
the O
MDI O
regimen O
revealed O
that O
RA O
mediated O
an O
elevated O
, O
prolonged O
expression O
of O
c B
- I
Jun I
mRNA I
accompanied O
by O
diminished O
expression O
of O
c B
- I
Fos I
and O
Jun B
- I
B I
mRNAs I
. O

Examination O
of O
immediate B
- I
early I
transcription I
factor I
expression O
during O
the O
MDI O
regimen O
revealed O
that O
RA O
mediated O
an O
elevated O
, O
prolonged O
expression O
of O
c B
- I
Jun I
mRNA I
accompanied O
by O
diminished O
expression O
of O
c B
- I
Fos I
and O
Jun B
- I
B I
mRNAs I
. O

The O
human B
ABCG1 I
gene I
encodes O
a O
member O
of O
the O
ATP B
- I
binding I
cassette I
( O
ABC B
) O
superfamily O
of O
transporter B
proteins I
and O
is O
highly O
induced O
when O
macrophages O
are O
incubated O
with O
oxysterols O
. O

Here O
we O
describe O
an O
in O
vitro O
assay O
where O
the O
NS3 B
- I
4A I
polyprotein I
, O
NS3 B
, O
the O
serine B
proteinase I
domain I
( I
the I
N I
- I
terminal I
181 I
residues I
of I
NS3 I
) I
, O
and O
the O
NS4A B
cofactor I
were O
produced O
by O
cell O
- O
free O
translation O
and O
tested O
for O
trans O
- O
processing O
of O
radiolabeled O
substrates O
. O

The O
RI B
alpha I
gene I
is O
composed O
of O
nine O
coding O
exons O
of O
varying O
lengths O
, O
separated O
by O
introns O
, O
giving O
the O
gene O
a O
total O
length O
of O
at O
least O
21 O
kb O
. O
our O
recent O
cloning O
of O
a O
processed O
RI B
alpha I
pseudogene I
with O
a O
5 O
' O
- O
noncoding O
region O
different O
from O
the O
previously O
reported O
RI B
alpha I
complementary I
RNA I
indicated O
that O
the O
RI B
alpha I
gene I
may O
have O
multiple O
leader O
exons O
giving O
rise O
to O
alternately O
spliced O
messenger O
RNAs O
( O
mRNAs O
) O
. O

While O
mutations O
in O
K B
- I
Rev I
that O
inactivate O
any O
one O
of O
these O
properties O
also O
blocked O
K B
- I
Rev I
- O
dependent O
nuclear O
RNA O
export O
, O
several O
K B
- I
Rev I
mutants I
were O
comparable O
to O
wild O
type O
when O
assayed O
for O
any O
of O
these O
individual O
activities O
yet O
nevertheless O
defective O
for O
RNA O
export O
. O

The O
algorithm O
also O
limited O
TG O
to O
20 O
and O
64 O
% O
, O
apoB B
to O
6 O
and O
20 O
% O
, O
and O
Lp B
( I
a I
) I
to O
15 O
and O
56 O
% O
, O
of O
low O
- O
and O
high O
- O
risk O
groups O
, O
respectively O
. O

By O
DNase B
I I
footprint O
analysis O
of O
the O
PNR O
element O
, O
a O
palindrome O
of O
two O
high O
- O
affinity O
Ets B
- I
binding I
sites I
( O
CTTCCCTGGAAG O
) O
was O
identified O
. O

The O
concentrations O
of O
apo B
A I
- I
I I
and O
apo B
A I
- I
II I
of O
abstainers O
decreased O
significantly O
compared O
with O
the O
corresponding O
changes O
in O
controls O
. O

The O
concentrations O
of O
apo B
A I
- I
I I
and O
apo B
A I
- I
II I
of O
abstainers O
decreased O
significantly O
compared O
with O
the O
corresponding O
changes O
in O
controls O
. O

The O
phenotypes O
of O
the O
ICP0 B
nonsense O
mutants O
were O
intermediate O
between O
those O
of O
the O
wild O
- O
type O
virus O
and O
7134 O
in O
that O
the O
more O
ICP0 B
- I
coding I
sequence I
expressed O
by O
a O
given O
nonsense O
mutant O
, O
the O
more O
wild O
type O
- O
like O
was O
its O
phenotype O
. O

These O
results O
suggest O
that O
the O
c B
- I
met I
gene I
is O
also O
a O
target O
of O
p53 B
gene I
regulation O
. O

TaqMan O
analysis O
of O
gene O
expression O
following O
chronic O
FA O
treatment O
showed O
neither O
a O
decrease O
in O
the O
amount O
of O
leptin B
receptor I
( O
Ob B
- I
R I
) O
mRNA O
, O
nor O
an O
increase O
in O
the O
negative O
regulators O
of O
STAT B
signalling O
, O
SOCS3 B
( O
suppressors B
of I
cytokine I
signalling I
) O
or O
cytokine B
inducible I
sequence I
( O
CIS B
) O
. O

We O
have O
determined O
the O
nucleotide O
( O
nt O
) O
sequence O
of O
the O
7 B
. I
5 I
- I
kb I
COR I
segment I
that O
encompasses O
a O
cluster O
of O
six O
genes O
( O
CYC1 B
, O
UTR1 B
, O
UTR3 B
, O
OSM1 B
, O
tRNA B
( I
Gly I
) I
and O
RAD7 B
) O
located O
on O
chromosome O
X O
of O
the O
yeast O
Saccharomyces O
cerevisiae O
. O

RUSH B
- I
1 I
beta I
is O
a O
95 O
- O
kDa O
truncated O
version O
of O
RUSH B
- I
1 I
alpha I
that O
results O
from O
alternative O
splicing O
of O
a O
57 O
- O
bp O
exon O
as O
confirmed O
by O
genomic O
cloning O
. O

RUSH B
- I
1 I
beta I
is O
a O
95 O
- O
kDa O
truncated O
version O
of O
RUSH B
- I
1 I
alpha I
that O
results O
from O
alternative O
splicing O
of O
a O
57 O
- O
bp O
exon O
as O
confirmed O
by O
genomic O
cloning O
. O

Anti B
- I
nucleolin I
mAb I
was O
used O
to O
confirm O
the O
antigenic O
properties O
of O
this O
p95 B
component I
. O

Overexpression O
of O
Trdpm1 B
in O
a O
dpm1 B
( I
+ I
) I
: O
: O
his7 B
/ I
dpm1 I
( I
+ I
) I
S O
. O
pombe O
diploid O
resulted O
in O
a O
4 O
- O
fold O
increase O
in O
specific O
DPM B
synthase I
activity O
. O

A O
full O
- O
length O
cDNA O
clone O
isolated O
from O
a O
rat O
lung O
library O
was O
predicted O
to O
encode O
a O
55 O
- O
kDa O
protein O
containing O
at O
its O
amino O
terminus O
a O
targeting O
domain O
that O
binds O
to O
the O
ANP B
- I
receptor I
kinase I
- I
like I
domain I
and O
containing O
at O
its O
carboxyl O
terminus O
a O
putative O
protein B
- I
serine I
phosphatase I
domain O
. O

Recent O
studies O
have O
demonstrated O
that O
the O
U1 B
snRNP I
is O
recruited O
to O
the O
5 O
' O
splice O
site O
by O
protein O
/ O
protein O
interactions O
involving O
the O
SR B
domains O
of O
the O
U1 B
- I
70K I
protein I
and O
SF2 B
/ O
ASF B
. O

Human O
T O
- O
cell O
leukemia O
virus O
type O
I O
Tax B
activation O
of O
NF B
- I
kappa I
B I
/ O
Rel B
involves O
phosphorylation O
and O
degradation O
of O
I B
kappa I
B I
alpha I
and O
RelA B
( I
p65 I
) I
- O
mediated O
induction O
of O
the O
c B
- I
rel I
gene I
. O

Human O
T O
- O
cell O
leukemia O
virus O
type O
I O
Tax B
activation O
of O
NF B
- I
kappa I
B I
/ O
Rel B
involves O
phosphorylation O
and O
degradation O
of O
I B
kappa I
B I
alpha I
and O
RelA B
( I
p65 I
) I
- O
mediated O
induction O
of O
the O
c B
- I
rel I
gene I
. O

Human O
T O
- O
cell O
leukemia O
virus O
type O
I O
Tax B
activation O
of O
NF B
- I
kappa I
B I
/ O
Rel B
involves O
phosphorylation O
and O
degradation O
of O
I B
kappa I
B I
alpha I
and O
RelA B
( I
p65 I
) I
- O
mediated O
induction O
of O
the O
c B
- I
rel I
gene I
. O

Human O
T O
- O
cell O
leukemia O
virus O
type O
I O
Tax B
activation O
of O
NF B
- I
kappa I
B I
/ O
Rel B
involves O
phosphorylation O
and O
degradation O
of O
I B
kappa I
B I
alpha I
and O
RelA B
( I
p65 I
) I
- O
mediated O
induction O
of O
the O
c B
- I
rel I
gene I
. O

Mutational O
analyses O
have O
demonstrated O
the O
importance O
of O
sequences O
within O
the O
327 O
bp O
segment O
that O
contain O
a O
putative O
cyclic B
AMP I
responsive I
element I
binding I
protein I
( O
CREB B
) O
binding O
site O
for O
TGF B
- I
beta I
1 I
and O
PMA O
responsiveness O
and O
putative O
PU B
- I
1 I
and O
Sp1 B
binding I
sites I
for O
basal O
promoter O
activity O
. O

The O
Ng B
/ I
RC3 I
and O
PKC B
- I
gamma I
genes I
have O
a O
similar O
expression O
pattern O
in O
the O
brain O
during O
development O
. O

The O
chloramphenicol B
- I
resistance I
transposon I
Tn4451 B
undergoes O
precise O
conjugative O
deletion O
from O
its O
parent O
plasmid O
plP401 O
in O
Clostridium O
perfringens O
and O
precise O
spontaneous O
excision O
from O
multicopy O
plasmids O
in O
Escherichia O
coli O
. O

Expression O
of O
a O
hybrid O
protein O
containing O
the O
cytoplasmic O
C O
- O
terminal O
half O
of O
UhpB B
fused O
to O
glutathione B
S I
- I
transferase I
( O
GST B
) O
also O
interfered O
with O
Uhp B
signaling O
. O

While O
these O
findings O
may O
reflect O
the O
sensitivity O
of O
a O
thick O
myocardial O
wall O
to O
ischaemia O
during O
surgery O
, O
the O
postoperative O
recovery O
was O
not O
related O
to O
the O
serum B
CK I
- I
MB I
level O
. O

The O
MXR B
gene I
encodes O
a O
half O
- O
transporter O
and O
the O
absence O
of O
cytogenetic O
evidence O
of O
coamplification O
of O
other O
regions O
suggests O
that O
a O
partner O
may O
not O
be O
overexpressed O
, O
and O
instead O
the O
MXR B
half I
- I
transporter I
homodimerizes O
to O
mediate O
drug O
transport O
. O

In O
contrast O
, O
exogenous B
PTHrP1 I
- I
34 I
and I
1 I
- I
86 I
peptides I
did O
not O
significantly O
affect O
IL B
- I
8 I
production O
; O
moreover O
, O
PTHrP B
- I
neutralizing I
antibodies I
did O
not O
inhibit O
the O
production O
of O
IL B
- I
8 I
by O
transfected O
PTHrP B
. O

MEKs B
and O
ERKs B
inhibited O
IL B
- I
6 I
activation O
of O
Stat3 B
harboring O
a O
mutation O
at O
serine O
- O
727 O
, O
the O
major O
site O
for O
serine O
phosphorylation O
, O
similar O
to O
inhibition O
of O
wild B
- I
type I
Stat3 I
, O
and O
inhibited O
Janus B
kinases I
Jak1 B
and O
Jak2 B
upstream O
of O
Stat3 B
in O
the O
Jak B
- O
STAT B
- O
signaling O
pathway O
. O

The O
titer O
of O
anti B
HSV I
type I
1 I
and O
anti B
HSV I
type I
2 I
antibodies I
in O
the O
mothers O
' O
and O
cord O
blood O
was O
determined O
and O
compared O
. O

Our O
observations O
suggest O
that O
members O
of O
the O
HMG B
- I
I I
family I
play O
an O
important O
role O
in O
SRF B
- O
dependent O
transcription O
and O
that O
their O
effect O
is O
mediated O
primarily O
by O
a O
protein O
- O
protein O
interaction O
. O

Upon O
differentiation O
with O
retinoic O
acid O
( O
RA O
) O
, O
transcription O
of O
the O
Rex B
- I
1 I
gene I
decreases O
rapidly O
. O

Hence O
, O
the O
replacement O
of O
Phe O
- O
62 O
with O
Ser O
specifically O
affects O
a O
determinant O
on O
the O
lambda B
I I
light I
chain I
that O
is O
necessary O
for O
the O
intracellular O
transport O
of O
this O
molecule O
. O

The O
Cdk2 B
- O
cyclin B
- I
D1 I
complex O
did O
not O
phosphorylate O
any O
tested O
substrates O
, O
such O
as O
H1 B
histone I
, O
pRB B
, O
SV40 B
large I
T I
antigen I
, O
p53 B
, O
E2F B
- I
1 I
or O
a O
preparation O
of O
nuclear O
proteins O
from O
HeLa O
cells O
; O
in O
contrast O
, O
Cdk2 B
- O
cyclin B
- I
E I
and O
Cdk2 B
- O
cyclin B
- I
A I
phosphorylated O
these O
proteins O
. O

Null O
mutations O
in O
daf B
- I
3 I
suppress O
mutations O
in O
genes O
encoding O
this O
TGF B
- I
beta I
signal O
, O
its O
receptors O
, O
and O
associated O
Smad B
signal I
transduction I
proteins I
. O

Mutation O
of O
the O
octamer O
element O
also O
significantly O
reduced O
the O
ability O
of O
HDAC1 B
to O
confer O
repression O
of O
inducible O
HLA B
- I
DRA I
promoter I
activation O
. O

In O
vitro O
interaction O
studies O
, O
using O
proteins O
fused O
to O
glutathione B
- I
S I
- I
transferase I
, O
showed O
that O
RBP B
- I
J I
kappa I
and O
Su B
( I
H I
) I
bind O
directly O
to O
the O
RAM23 B
regions I
of O
mouse B
Notch1 I
and O
Drosophila B
Notch I
, O
respectively O
. O

In O
vitro O
interaction O
studies O
, O
using O
proteins O
fused O
to O
glutathione B
- I
S I
- I
transferase I
, O
showed O
that O
RBP B
- I
J I
kappa I
and O
Su B
( I
H I
) I
bind O
directly O
to O
the O
RAM23 B
regions I
of O
mouse B
Notch1 I
and O
Drosophila B
Notch I
, O
respectively O
. O

We O
conclude O
that O
c B
- I
Myb I
regulates O
the O
RAG B
- I
2 I
promoter I
in O
T O
cells O
by O
binding O
to O
this O
consensus B
c I
- I
Myb I
binding I
site I
. O

We O
show O
that O
the O
mouse O
genome O
contains O
four O
copies O
of O
the O
ubc B
- I
9 I
gene I
. O

The O
carboxyl O
- O
terminal O
transactivation O
domain O
of O
heat B
shock I
factor I
1 I
is O
negatively O
regulated O
and O
stress O
responsive O
. O

The O
438 B
bp I
EcoRI I
fragment I
, O
which O
was O
detected O
by O
Southern O
hybridization O
, O
reveals O
an O
open O
reading O
frame O
which O
encodes O
a O
protein O
of O
103 O
amino O
acids O
. O

The O
localization O
of O
ZAP B
- I
70 I
to O
the O
cell O
cortex O
is O
, O
therefore O
, O
regulated O
by O
the O
activity O
of O
SRC B
- I
family I
kinases I
, O
independently O
of O
their O
ability O
to O
phosphorylate O
immunoreceptor O
tyrosine O
- O
based O
activation O
motifs O
of O
the O
TCR B
. O

However O
, O
we O
could O
not O
find O
the O
homologous O
regions O
with O
guanine B
nucleotide I
exchange I
factors I
or O
GTPase B
- I
activating I
proteins I
in O
the O
c B
- I
cbl I
gene I
. O

However O
, O
we O
could O
not O
find O
the O
homologous O
regions O
with O
guanine B
nucleotide I
exchange I
factors I
or O
GTPase B
- I
activating I
proteins I
in O
the O
c B
- I
cbl I
gene I
. O

However O
, O
we O
could O
not O
find O
the O
homologous O
regions O
with O
guanine B
nucleotide I
exchange I
factors I
or O
GTPase B
- I
activating I
proteins I
in O
the O
c B
- I
cbl I
gene I
. O

Genes O
for O
ocs B
element I
binding I
factors I
( O
OBFs B
) O
, O
belonging O
to O
a O
specific O
class O
of O
basic B
- I
region I
leucine I
zipper I
( I
bZIP I
) I
transcription I
factors I
, O
have O
been O
isolated O
in O
a O
number O
of O
plants O
. O

We O
have O
investigated O
the O
requirements O
of O
the O
CH B
gene I
switch O
by O
characterizing O
two O
rearranged B
gamma I
2b I
genes I
from O
a O
gamma B
2b I
producing O
mouse O
myeloma O
( O
MPC O
- O
11 O
) O
. O

Two O
mammalian O
enzymes O
, O
the O
haem B
- I
controlled I
repressor I
( O
HCR B
) O
and O
the O
double B
- I
stranded I
RNA I
- I
activated I
inhibitor I
( O
dsI B
) O
, O
phosphorylate O
Ser O
- O
51 O
of O
the O
alpha O
subunit O
, O
thereby O
inhibiting O
the O
exchange O
of O
bound O
nucleotides O
on O
, O
and O
thus O
the O
recycling O
of O
, O
eIF B
- I
2 I
. O

As O
a O
result O
, O
we O
have O
defined O
two O
arginine O
- O
rich O
motifs O
( O
ARM1 O
and O
ARM2 O
) O
that O
mediate O
the O
RNA O
binding O
activity O
of O
SU B
( I
S I
) I
. O

Based O
on O
16S B
rRNA I
gene I
sequence I
analysis O
, O
the O
11 O
species O
having O
two O
tuf B
genes I
all O
have O
a O
common O
ancestor O
, O
while O
the O
six O
species O
having O
only O
one O
copy O
diverged O
from O
the O
enterococcal O
lineage O
before O
that O
common O
ancestor O
. O

Furthermore O
, O
deletion O
and O
mutation O
analyses O
of O
the O
VCAM B
- I
1 I
promoter I
performed O
with O
chloramphenicol B
acetyltransferase I
constructs I
revealed O
that O
Tax B
was O
trans O
activating O
the O
VCAM B
- I
1 I
promoter I
via O
two O
NF B
- I
kappaB I
sites I
present O
at O
bp O
- O
72 O
and O
- O
57 O
in O
the O
VCAM B
- I
1 I
gene I
promoter I
, O
with O
both O
of O
them O
being O
required O
for O
the O
Tax B
- O
induced O
expression O
of O
this O
adhesion O
molecule O
. O

Furthermore O
, O
deletion O
and O
mutation O
analyses O
of O
the O
VCAM B
- I
1 I
promoter I
performed O
with O
chloramphenicol B
acetyltransferase I
constructs I
revealed O
that O
Tax B
was O
trans O
activating O
the O
VCAM B
- I
1 I
promoter I
via O
two O
NF B
- I
kappaB I
sites I
present O
at O
bp O
- O
72 O
and O
- O
57 O
in O
the O
VCAM B
- I
1 I
gene I
promoter I
, O
with O
both O
of O
them O
being O
required O
for O
the O
Tax B
- O
induced O
expression O
of O
this O
adhesion O
molecule O
. O

Furthermore O
, O
deletion O
and O
mutation O
analyses O
of O
the O
VCAM B
- I
1 I
promoter I
performed O
with O
chloramphenicol B
acetyltransferase I
constructs I
revealed O
that O
Tax B
was O
trans O
activating O
the O
VCAM B
- I
1 I
promoter I
via O
two O
NF B
- I
kappaB I
sites I
present O
at O
bp O
- O
72 O
and O
- O
57 O
in O
the O
VCAM B
- I
1 I
gene I
promoter I
, O
with O
both O
of O
them O
being O
required O
for O
the O
Tax B
- O
induced O
expression O
of O
this O
adhesion O
molecule O
. O

mRNA O
for O
the O
HPV O
E6 B
/ O
E7 B
genes O
decreased O
; O
however O
, O
significant O
changes O
in O
the O
E7 B
protein I
were O
not O
observed O
, O
while O
increased O
levels O
of O
Rb B
immunoprecipitated O
with O
anti B
- I
E7 I
antibodies I
were O
observed O
. O

Thyrotropin B
- I
releasing I
hormone I
- O
induced O
contraction O
of O
urethral O
and O
vaginal O
muscle O
. O

Moreover O
, O
promoters O
containing O
a O
TATA O
box O
in O
the O
absence O
of O
Sp1 B
sites I
or O
Sp1 B
sites I
in O
the O
absence O
of O
a O
TATA O
box O
were O
equally O
inducible O
in O
vitro O
, O
as O
was O
an O
RNA B
polymerase I
III I
promoter I
. O

The O
yeast O
gene O
that O
encodes O
eIF B
- I
5 I
, O
designated O
TIF5 B
, O
has O
been O
isolated O
and O
expressed O
in O
Escherichia O
coli O
to O
yield O
a O
catalytically O
active O
eIF B
- I
5 I
protein I
. O

One O
patients O
had O
plasma B
C I
- I
peptide I
greater O
than O
3 O
pM O
and O
was O
therefore O
excluded O
from O
analysis O
. O

Weak O
allergenicity O
of O
recombinant B
hirudin I
CGP I
39393 I
( O
REVASC O
) O
in O
immunocompetent O
volunteers O
. O

